Revive Therapeutics Ltd. RVVTF · Stock Open Revive Therapeutics Ltd. in new tab
Revive Therapeutics Ltd. Analysis (RVVTF)
Is Revive Therapeutics Ltd. a good investment? Revive Therapeutics Ltd. (RVVTF) is currently trading at 0.0161 USD.
Earnings Schedule: Revive Therapeutics Ltd. is expected to release its next earnings report on May 27, 2026.
Investor FAQ
Does Revive Therapeutics Ltd. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Revive Therapeutics Ltd.?
Revive Therapeutics Ltd. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be May 27, 2026. The company currently has a trailing EPS of -0.02.
Company Profile
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.
| Split Date | Split Ratio to 1 |
|---|---|
| May 20, 2016 | 1.27 |
Community Discussion